Showing 781 - 800 results of 2,004 for search '"Breast cancer"', query time: 0.08s Refine Results
  1. 781

    Proteomic profiling identifies upregulation of aurora kinases causing resistance to taxane-type chemotherapy in triple negative breast cancer by Bohan Ning, Chang Liu, Ali Cem Kucukdagli, Jiuyi Zhang, Han Jing, Zhiqian Zhou, Yuwei Zhang, Ying Dong, Yunjia Chen, Hua Guo, Jia Xu

    Published 2025-01-01
    “…Abstract Nowadays, chemotherapy and immunotherapy remain the major treatment strategies for Triple-Negative Breast Cancer (TNBC). Identifying biomarkers to pre-select and subclassify TNBC patients with distinct chemotherapy responses is essential. …”
    Get full text
    Article
  2. 782
  3. 783
  4. 784

    L3MBTL3 and STAT3 collaboratively upregulate SNAIL expression to promote metastasis in female breast cancer by Jianpeng Xiao, Jie Wang, Jialun Li, Jie Xiao, CuiCui Liu, Libi Tan, Yanhong Tu, Ruifang Yang, Yujie Pei, Minghua Wang, Jiemin Wong, Binhua P. Zhou, Jing Li, Jing Feng

    Published 2025-01-01
    “…In our study, the lysine methylation binding protein L3MBTL3 is positively associated with metastasis and poor prognosis in female patients with breast cancer. L3MBTL3 also promotes epithelial–mesenchymal transition and metastasis in breast cancer. …”
    Get full text
    Article
  5. 785
  6. 786

    Associations between phenol and paraben exposure and the risk of developing breast cancer in adult women: a cross-sectional study by Yao Xiong, Zhiyu Li, Xiong Xiong, Zixuan Luo, Kaixin Zhong, Jiawei Hu, Shengrong Sun, Chuang Chen

    Published 2025-02-01
    “…Abstract Increasing evidence suggests that endocrine-disrupting chemicals (EDCs) have adverse effects on breast cancer (BC). The aim of this study was to assess the association between exposure to prevalent EDCs—phenols and parabens—and the risk of developing BC. …”
    Get full text
    Article
  7. 787
  8. 788

    Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes by Claudia Omarini, Virginia Catani, Ilenia Mastrolia, Angela Toss, Federico Banchelli, Chrystel Isca, Daniele Medici, Ornella Ponzoni, Marco Brucale, Francesco Valle, Maria Cristina Baschieri, Roberto D’Amico, Valentina Masciale, Chiara Chiavelli, Federica Caggia, Carlo Augusto Bortolotti, Federico Piacentini, Massimo Dominici

    Published 2025-01-01
    “…However, limited knowledge exists on the levels and clinical meaning of miR-21 in extracellular vesicles (EVs) of patients with breast cancer (BC). We assessed EV-derived miR-21 levels in one hundred women: 30 with early BC (EBC), 30 with metastatic BC on treatment progression (MBC), 30 cancer survivors on follow-up (FU) and 10 healthy donors (HD) as age- and body mass index (BMI)-matched controls. …”
    Get full text
    Article
  9. 789
  10. 790
  11. 791
  12. 792
  13. 793
  14. 794

    Identifying Safeguards Disabled by Epstein-Barr Virus Infections in Genomes From Patients With Breast Cancer: Chromosomal Bioinformatics Analysis by Bernard Friedenson

    Published 2025-01-01
    “… Abstract BackgroundThe causes of breast cancer are poorly understood. A potential risk factor is Epstein-Barr virus (EBV), a lifelong infection nearly everyone acquires. …”
    Get full text
    Article
  15. 795
  16. 796

    Cost Effectiveness Analysis of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer in Spain: Management in the Later Line of Therapy by Gabriel Tremblay, Unnati Majethia, Ilias Kontoudis, Jesús De Rosendo

    Published 2015-10-01
    “…**Background:** Two thirds (62%) of metastatic breast cancer (MBC) patients in Western Europe have human epidermal growth factor receptor 2 (HER2)-negative disease, for which anthracyclines and taxanes are recommended as first-line treatments, followed by microtubule-targeting agents such as capecitabine, vinorelbine and/or eribulin. …”
    Get full text
    Article
  17. 797
  18. 798
  19. 799

    The meaning of trust along the treatment pathway of women with breast cancer: a mixed-methods study among cancer survivors by Eleonore Baum, Daniela Bernhardsgrütter, Ramona Engst, Carola Maurer, Jessica Ebneter, Adrienne Zenklusen, Barbara Wartlsteiner, Lotti Barandun, Andrea Neher, Antje Koller, Andrea Kobleder

    Published 2025-01-01
    “…Abstract Purpose Women with breast cancer face a high degree of uncertainty. Trust between health providers and patients has been shown to improve patient quality of life and may enhance clinical outcomes. …”
    Get full text
    Article
  20. 800

    A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer by Xin Zhang, Xingda Zhang, Guozheng Li, Yi Hao, Lei Liu, Lei Zhang, Yihai Chen, Jiale Wu, Xinheng Wang, Shuai Yang, Shouping Xu

    Published 2022-01-01
    “…Breast cancer (BRCA) is one of the leading causes of death among women worldwide, and drug resistance often leads to a poor prognosis. …”
    Get full text
    Article